These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31479256)

  • 1. Consequence of Hapten Stereochemistry: An Efficacious Methamphetamine Vaccine.
    Olson ME; Sugane T; Zhou B; Janda KD
    J Am Chem Soc; 2019 Sep; 141(36):14089-14092. PubMed ID: 31479256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines.
    Carroll FI; Blough BE; Pidaparthi RR; Abraham P; Gong PK; Deng L; Huang X; Gunnell M; Lay JO; Peterson EC; Owens SM
    J Med Chem; 2011 Jul; 54(14):5221-8. PubMed ID: 21682289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of distinct chemical structures for the development of a methamphetamine vaccine.
    Moreno AY; Mayorov AV; Janda KD
    J Am Chem Soc; 2011 May; 133(17):6587-95. PubMed ID: 21473576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influencing Antibody-Mediated Attenuation of Methamphetamine CNS Distribution through Vaccine Linker Design.
    Gooyit M; Miranda PO; Wenthur CJ; Ducime A; Janda KD
    ACS Chem Neurosci; 2017 Mar; 8(3):468-472. PubMed ID: 27958709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid tucaresol as an adjuvant for methamphetamine vaccine development.
    Collins KC; Schlosburg JE; Lockner JW; Bremer PT; Ellis BA; Janda KD
    Chem Commun (Camb); 2014 Apr; 50(31):4079-81. PubMed ID: 24615284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of a novel anti-nicotine vaccine: influence of antigen design on antibody function in mice.
    Pryde DC; Jones LH; Gervais DP; Stead DR; Blakemore DC; Selby MD; Brown AD; Coe JW; Badland M; Beal DM; Glen R; Wharton Y; Miller GJ; White P; Zhang N; Benoit M; Robertson K; Merson JR; Davis HL; McCluskie MJ
    PLoS One; 2013; 8(10):e76557. PubMed ID: 24098532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines.
    Duryee MJ; Bevins RA; Reichel CM; Murray JE; Dong Y; Thiele GM; Sanderson SD
    Vaccine; 2009 May; 27(22):2981-8. PubMed ID: 19428909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine Vaccines: Improvement through Hapten Design.
    Collins KC; Schlosburg JE; Bremer PT; Janda KD
    J Med Chem; 2016 Apr; 59(8):3878-85. PubMed ID: 27054372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthesis of haptens and their use for the development of monoclonal antibodies for treating methamphetamine abuse.
    Carroll FI; Abraham P; Gong PK; Pidaparthi RR; Blough BE; Che Y; Hampton A; Gunnell M; Lay JO; Peterson EC; Owens SM
    J Med Chem; 2009 Nov; 52(22):7301-9. PubMed ID: 19877685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats.
    Miller ML; Moreno AY; Aarde SM; Creehan KM; Vandewater SA; Vaillancourt BD; Wright MJ; Janda KD; Taffe MA
    Biol Psychiatry; 2013 Apr; 73(8):721-8. PubMed ID: 23098894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and immunological effects of heroin vaccines.
    Li F; Cheng K; Antoline JF; Iyer MR; Matyas GR; Torres OB; Jalah R; Beck Z; Alving CR; Parrish DA; Deschamps JR; Jacobson AE; Rice KC
    Org Biomol Chem; 2014 Oct; 12(37):7211-32. PubMed ID: 24995943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.
    Jalah R; Torres OB; Mayorov AV; Li F; Antoline JF; Jacobson AE; Rice KC; Deschamps JR; Beck Z; Alving CR; Matyas GR
    Bioconjug Chem; 2015 Jun; 26(6):1041-53. PubMed ID: 25970207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of a Heroin Vaccine through Hapten Deuteration.
    Belz TF; Bremer PT; Zhou B; Ellis B; Eubanks LM; Janda KD
    J Am Chem Soc; 2020 Aug; 142(31):13294-13298. PubMed ID: 32700530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuse.
    Collins KC; Janda KD
    Bioconjug Chem; 2014 Mar; 25(3):593-600. PubMed ID: 24521489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine development against methamphetamine drug addiction.
    Hossain MK; Hassanzadeganroudsari M; Nurgali K; Apostolopoulos V
    Expert Rev Vaccines; 2020 Dec; 19(12):1105-1114. PubMed ID: 33251859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat shock proteins: A dual carrier-adjuvant for an anti-drug vaccine against heroin.
    Hwang CS; Ellis B; Zhou B; Janda KD
    Bioorg Med Chem; 2019 Jan; 27(1):125-132. PubMed ID: 30497790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-nicotine vaccines: Comparison of adjuvanted CRM197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primates.
    McCluskie MJ; Thorn J; Gervais DP; Stead DR; Zhang N; Benoit M; Cartier J; Kim IJ; Bhattacharya K; Finneman JI; Merson JR; Davis HL
    Int Immunopharmacol; 2015 Dec; 29(2):663-671. PubMed ID: 26404190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple radiometric method for accurately quantitating epitope densities of hapten-protein conjugates with sulfhydryl linkages.
    Peterson EC; Hambuchen MD; Tawney RL; Gunnell MG; Cowell JL; Lay JO; Blough BE; Carroll FI; Owens SM
    Bioconjug Chem; 2014 Dec; 25(12):2112-5. PubMed ID: 25426820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and characterization of a novel conjugated methamphetamine vaccine.
    Kamal Hossain M; Davidson M; Feehan J; Deraos G; Nurgali K; Matsoukas J; Apostolopoulos V
    Vaccine; 2022 Sep; 40(41):5882-5891. PubMed ID: 36041942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Clinically Viable Heroin Vaccine.
    Bremer PT; Schlosburg JE; Banks ML; Steele FF; Zhou B; Poklis JL; Janda KD
    J Am Chem Soc; 2017 Jun; 139(25):8601-8611. PubMed ID: 28574716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.